Skip to main content

Table 1 Comparison of demographic characteristics between groups

From: Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease

Items

SAP group (n = 48)

UAP group (n = 46)

AMI group (n = 43)

Control group (n = 145)

Z/χ2

P value

Age (years)

48.4 ± 10.2

51.3 ± 10.7

53.8 ± 11.0

52.7 ± 10.3

2.589

0.053

Gender (male/female)

27/21

25/21

24/19

78/60

0.068

0.995

BMI (kg/m2)

24.61 ± 2.42*

24.99 ± 2.48*

25.59 ± 2.51*

22.13 ± 2.21

37.839

 < 0.001

Smoking history (n)

7*

8*

9*

3

20.477

 < 0.001

Alcohol consumption history (n)

7*

7*

10*

2

24.398

 < 0.001

Hypertension history (n)

28*

28*

27*

0

124.706

 < 0.001

Diabetes history (n)

16*

16*

15*

0

59.744

 < 0.001

TC (mmol/L)

4.69 ± 0.78*

4.83 ± 0.81*

4.98 ± 0.83*

3.19 ± 0.79

99.996

 < 0.001

HDL-C (mmol/L)

1.22 ± 0.21*

1.16 ± 0.19*

1.09 ± 0.18*

1.43 ± 0.22

42.797

 < 0.001

LDL-C (mmol/L)

2.43 ± 0.46*

2.55 ± 0.47*

2.62 ± 0.49*

1.83 ± 0.51

48.594

 < 0.001

TG (mmol/L)

1.68 ± 0.19*

1.73 ± 0.21*

1.79 ± 0.24*

1.33 ± 0.21

87.874

 < 0.001

FBG (mmol/L)

6.57 ± 0.81*

6.63 ± 0.79*

6.89 ± 0.82*

5.18 ± 0.78

86.594

 < 0.001

Medication (n, %)

Aspirin

46

45

42

–

0.407

0.816

Statins

47

46

42

–

1.035

0.596

Nitrate

37

36

33

 

0.033

0.984

β-blocker

30

32

30

–

0.726

0.696

ACEI/ARB

24

24

23

–

0.114

0.945

  1. Compared with the control group (*P < 0.05)
  2. SAP stable angina pectoris, UAP unstable angina pectoris, AMI acute myocardial infarction, BMI body mass index, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglyceride, FBG fasting blood-glucose, ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers